Source: Expert Opinion on Drug Discovery. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS
ABNT
MURTA, Silvane Maria Fonseca et al. New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease. Expert Opinion on Drug Discovery, v. 19, n. 6, p. 741-753, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/17460441.2024.2349155. Acesso em: 27 ago. 2024.APA
Murta, S. M. F., Santana, P. A. L., Lapierre, thibault J. W. J. D., Penteado, A. B., Hajje, M. E., Liarte, D. B., et al. (2024). New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease. Expert Opinion on Drug Discovery, 19( 6), 741-753. doi:10.1080/17460441.2024.2349155NLM
Murta SMF, Santana PAL, Lapierre thibault JWJD, Penteado AB, Hajje ME, Liarte DB, Souza ML de, Trossini GHG, Rezende Junior C de O, Oliveira RB de, Ferreira RS. New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease [Internet]. Expert Opinion on Drug Discovery. 2024 ; 19( 6): 741-753.[citado 2024 ago. 27 ] Available from: https://dx.doi.org/10.1080/17460441.2024.2349155Vancouver
Murta SMF, Santana PAL, Lapierre thibault JWJD, Penteado AB, Hajje ME, Liarte DB, Souza ML de, Trossini GHG, Rezende Junior C de O, Oliveira RB de, Ferreira RS. New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease [Internet]. Expert Opinion on Drug Discovery. 2024 ; 19( 6): 741-753.[citado 2024 ago. 27 ] Available from: https://dx.doi.org/10.1080/17460441.2024.2349155